{
    "code": "02022756",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02022756",
    "time": "2020-02-25 12:58:46",
    "許可證字號": "衛署藥輸字第022756號",
    "註銷狀態": "已註銷",
    "註銷日期": "102\/12\/16",
    "註銷理由": "未展延而逾期者",
    "製造許可登錄編號": "",
    "有效日期": "99\/01\/11",
    "發證日期": "89\/01\/11",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202275605",
    "中文品名": "施博勞錠",
    "英文品名": "SPARA TABLET",
    "適應症": "對ＳＰＡＲＦＬＯＸＡＣＩＮ具有感受性之細菌所引起之呼吸道感染、中耳炎、竇炎、眼感染、腎臟及泌尿道感染（包括淋病）、腹部感染（包括腹膜炎）、皮膚及軟組織感染、骨髓炎、關節感染、菌血症。",
    "劑型": "116膜衣錠",
    "包裝": "2-1000錠鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "SPARFLOXACIN",
    "限制項目": "02輸　入",
    "申請商名稱": "1406801200  臺灣東洋藥品工業股份有限公司",
    "申請商地址": "台北市南港區園區街3之1號3樓",
    "主製造廠": [
        {
            "製造廠名稱": "FJP0043200  DAINIPPON PHARMACEUTICAL CO., LTD. (SUZUKA PLANT)",
            "製造廠廠址": "1450 YASUZUKA-CHO SUZUKA CITY MIE JAPAN",
            "製造廠公司地址": "",
            "製造廠國別": "JAPAN",
            "製程": ""
        }
    ],
    "CCC號列": "30042000916 人用醫藥製劑，含有其他抗生素者Medicaments, containing other antibiotics, for human use",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0812700800",
            "成分名稱": "SPARFLOXACIN",
            "含量描述": "100",
            "含量": "100.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "白色",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "八邊形",
        "標記一": "P,332",
        "標記二": "100"
    },
    "藥物辨識外觀圖片": [
        {
            "title": "02022756.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022756&Seq=435&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "020227560004.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022756&Seq=004&Type=9"
        }
    ]
}